ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382046 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382046; 2) Community: the network communities that were significantly associated with the response to NSC 382046; 3) Molecule: the relationships between components within communities and NSC 382046; 4) MDR: the compounds that were significantly associated with the NSC 382046.

NSC Compound Enrichment Correlation
NSC 720495 Null 0.0434721470609156 0.16087063
NSC 726217 Combretastatin A4-analogue 0.0434721470609156 0.56340736
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.0434721470609156 0.3834913
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0434721470609156 0.53351982
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0434721470609156 0.39923194
NSC 734288 6-(3-Azidopropyl)-5,6-dihydro-7,8-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.0434721470609156 0.48863278
NSC 740357 Null 0.0434721470609156 -0.0099541296
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0434721470609156 0.40509811
NSC 750050 Null 0.0434721470609156 0.41570336
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0434721470609156 0.4500242
Total:145  Current:117    [First] [Prev] [Next] [Last]